Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Threshold Pharma claims new camptothecin derivatives for cancer therapy

Jan. 17, 2011

CVA21 and doxorubicin demonstrate synergistic anticancer activity in vivo

Jan. 17, 2011

Novel kinase inhibitors identified at Abraxis BioScience

Jan. 17, 2011

Daiichi Sankyo and ArQule initiate phase III trial of ARQ-197 in NSCLC

Jan. 14, 2011

Pfizer initiates rolling NDA submission for crizotinib for NSCLC

Jan. 14, 2011

Enzon begins phase I study of EZN-4176 in castration-resistant prostate cancer

Jan. 14, 2011

Lilly presents new inhibitors of hedgehog signaling

Jan. 14, 2011

Cannabinoid CB1/CB2 receptors show promise as targets in NSCLC

Jan. 14, 2011

Phase IIb trial evaluates budesonide as chemopreventive therapy in subjects with lung nodules

Jan. 14, 2011

XL-184 receives FDA orphan drug status and is assigned generic name cabozantinib

Jan. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...